The vFFR workflow builds a 3D reconstruction of coronary artery and assesses pressure drop, resulting in a vFFR value. Furthermore, the 3D reconstruction enables assessment of severity and percentage of stenosis.
Functional lesion information
-
Pressure drops in coronary artery
-
vFFR value
Anatomical lesion information
-
Lesion diameter
-
Percentage stenosis
-
Reference diameter
-
Obstruction length
Clinical Evidence
- vFFR is subject of two multi-center randomized clinical trials investigating the effectiveness of vFFR guided revascularization vs FFR guided revascularization in over 4000 patients:
- The FASTIII trial is led by Dr. Joost Daemen (Erasmus Medical Center, Rotterdam, The Netherlands) , investigator initiated and sponsored by the European Cardiovascular Research Institute (ECRI). All study details can be found here: https://www.ecri-trials.com/studies/fast-iii/
-
The LIPSIA STRATEGY trial is led by Prof. Holger Thiele (Herzzentrum Leipzig) and investigator initiated. More information can be found here: https://www.clinicaltrials.gov/ct2/show/NCT03497637
-
vFFR is and has been subject to multiple single and multi-center trials investigating diagnostic accuracy to predict FFR ≤ 0.8, accuracy in post-PCI setting and accuracy related to IVUS, OCT, NHPR. A full overview can be found here.
Key product features
Contact information
Why choose us?
We always aim to improve the quality and efficiency of cardiovascular image analysis to optimize patient treatment. To realize this, we:
- Provide fast and user-friendly software;
- Align our product portfolio with the latest developments in the cardiovascular field. In this way we aim to provide our customers with the optimal software solution at the right time;
- Offer training options which can be tailored to your needs.
We believe in the importance of training and support to assure that all our users are proficient and comfortable with their analysis. Please visit our Training & Support page for more information.